By providing your information, you agree to our Terms of Use and our Privacy Policy. We use vendors that may also process your information to help provide our services. This site is protected by reCAPTCHA Enterprise and the Google Privacy Policy and Terms of Service apply.
Helex, US head-quartered, uses CRISPR technology to enable safer gene editing, which provides a workable therapy to millions of people suffering from rare genetic disorders that have so far have no cure. I'll be talking to Rohini Kalvakuntla, co-founder of the company. It was founded in 2021, is hq-ed in NewYork. ( Indian Founders.). Helex was one of the only Indian companies part of IndieBio- world's largest biotech accelerator backed by SOSV. It is is a partner from lab to commercialization, ultimately helping therapeutic companies fasten their time to market.